Physician profile
Karen L Mcquade
NPI 1750592234
$2,299.84
in general payments reported to CMS, 2019-2025
31 companies · $536 in 2025
The $536 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.54 · 2020: $15.61 · 2021: $461 · 2022: $183 · 2023: $202 · 2024: $833 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,571.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $386.46 | 2021-2024 | Diamondback Peripheral, Absolute Pro, Jeti All In One Non-Sterile Kit |
| Stryker Corporation | $227.41 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Bolton Medical INC | $190.28 | 2024-2025 | Treo Abdominal Stent-Graft System |
| Cardiovascular Systems INC. | $174.21 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $170.28 | 2021 | |
| Integra Lifesciences Corporation | $165.64 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Tactile Systems Technology INC | $138.77 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Medtronic, INC. | $101.32 | 2024-2025 | Ellipsys Vascular Access System, Endurant Iis, Abre |
| Biotissue Holdings INC. | $81.40 | 2022 | |
| Cvrx, INC. | $70.46 | 2022-2023 | Barostim Neo System |
| Endologix LLC | $63.98 | 2025 | Endocross Device, Torus Stent Graft System |
| Cordis US Corp. | $59.15 | 2021-2024 | Mynxgrip, Outback Elite |
| Kerecis Limited | $58.99 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Shockwave Medical, INC | $49.29 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Mimedx Group, INC. | $46.31 | 2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cashflow Solutions, LLC | $35.91 | 2023-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Shionogi INC | $27.02 | 2019 | |
| Cardinal Health 200 LLC | $24.73 | 2021 | |
| Innovation Technologies INC | $23.71 | 2024 | Irrisept |
| Inari Medical, INC. | $21.45 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $20.93 | 2024 | |
| Ossur Americas, INC. | $19.27 | 2025 | |
| Progenacare Global, LLC | $18.54 | 2023 | |
| Neuros Medical, INC. | $17.94 | 2025 | Altius |
| Resmed Corp | $17.60 | 2022 | |
| Teleflex LLC | $17.24 | 2021 | |
| Angiodynamics, INC. | $16.45 | 2023 | Auryon Laser System 100-120 Vac |
| Mallinckrodt Hospital Products INC. | $15.61 | 2020 | |
| Lemaitre Vascular, INC. | $14.38 | 2025 | Artegraft Vascular Graft |
| Cook Medical LLC | $13.59 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Mcquade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.